Enzyme Linked Immunosorbent Assay Market, by Method (Direct ELISA, Indirect ELISA, Sandwich ELISA and Competitive ELISA), by Application (Vaccine Development, Immunology, Diagnostics, Toxicology, Drug Monitoring & Pharmaceutical Industry & Transplantation

Enzyme Linked Immunosorbent Assay Market, by Method (Direct ELISA, Indirect ELISA, Sandwich ELISA and Competitive ELISA), by Application (Vaccine Development, Immunology, Diagnostics, Toxicology, Drug Monitoring & Pharmaceutical Industry & Transplantation), by Technology (Chemiluminescent, Colorimetric, & Fluorescent), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Enzyme Linked Immunosorbent Assay (ELISA) is an immunoassay used to identify proteins, peptides, antibodies, and hormones. ELISA assay has application in biotechnology medicine, as a diagnostic tool, which detects color change to identify a target substance and measures its concentration in the test sample. The common diagnostic applications of ELISA are (Human Immunodeficiency Virus) HIV infection, pregnancy tests, and measurement of cytokines, soluble proteins, and others. Various antigen-antibody combinations are used in the immunoassay that include an enzyme-labeled antigen or antibody and enzyme activity is measured. On the basis of antigen-antibody combination, the assay is segmented into direct ELISA, indirect ELISA, sandwich ELISA, and competitive ELISA. Increasing prevalence of infectious disease such as HIV and increasing awareness regarding diagnosis of cancer and autoimmune diseases are major factors propelling demand for ELISA to reduce the burden of chronic diseases with early and accurate disease diagnosis.

Market Dynamics

Increasing product launches by market players is expected to of drive growth of the global Enzyme Linked Immunosorbent Assay (ELISA) Market over the forecast period. For instance, On June 17, 2020, J Mitra & Co Pvt Ltd, a global company in the In-Vitro Diagnostics (IVD) industry had launched COVID-19 total antibody detection Elisa test kit in the Indian market. It is a Double-Sandwich Elisa technology, the test kit is known as COVID-19 [IgM, IgG, IgA] MICROLISA. It is a serology-based total antibody (IgM, IgG, IgA) detection assay. All the COVID-19 antibodies are detected without differentiation in antibodies, and this is the reason contributing to the superior performance of this test.

Key features of the study:

• This report provides an in-depth analysis of the global Enzyme Linked Immunosorbent Assay (ELISA) Market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global Enzyme Linked Immunosorbent Assay (ELISA) Market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Bio-Rad Laboratories, Inc., Enzo Life Sciences, Inc., Thermo Fisher Scientific, Inc., Biomerieux S.A., Alpco, BioLegand, Inc., R&D Systems, Creative Diagnostics, Zeus Scientific, Inc., and Shenzhen YHLO Biotech Co., Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global Enzyme Linked Immunosorbent Assay (ELISA) Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Enzyme Linked Immunosorbent Assay (ELISA) Market

Detailed Segmentation:

• Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Method:
• Direct ELISA
• Indirect ELISA
• Sandwich ELISA
• Competitive ELISA
• Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Application:
• Vaccine Development
• Immunology
• Diagnostics
• Toxicology
• Drug Monitoring & Pharmaceutical Industry
• Transplantation
• Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Technology:
• Chemiluminescent
• Colorimetric
• Fluorescent
• Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Region:
• North America
• By Country
• U.S.
• Canada
• Latin America
• By Country:
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By Country
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Country
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• By Country
• GCC
• Israel
• Rest of Middle East
• Africa
• By Region/Country
• South Africa
• Central Africa
• North Africa
• Company Profiles
• Bio-Rad Laboratories, Inc.*
• Company Highlights
• Products Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Enzo Life Sciences, Inc.
• Thermo Fisher Scientific, Inc.
• Biomerieux S.A.
• Alpco
• BioLegand, Inc.
• R&D Systems
• Creative Diagnostics
• Zeus Scientific, Inc.
• Shenzhen YHLO Biotech Co., Ltd.

“*” marked represents similar segmentation in other categories in the respective section.